Medication Safety Principles and Practice in CKD
Ensuring patient safety is a priority of medical care because iatrogenic injury has been a primary concern. Medications are an important source of medical errors, and kidney disease is a thoroughfare of factors threatening safe administration of medicines. Principal among these is reduced kidney fun...
Gespeichert in:
Veröffentlicht in: | Clinical journal of the American Society of Nephrology 2018-11, Vol.13 (11), p.1738-1746 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1746 |
---|---|
container_issue | 11 |
container_start_page | 1738 |
container_title | Clinical journal of the American Society of Nephrology |
container_volume | 13 |
creator | Whittaker, Chanel F Miklich, Margaret A Patel, Roshni S Fink, Jeffrey C |
description | Ensuring patient safety is a priority of medical care because iatrogenic injury has been a primary concern. Medications are an important source of medical errors, and kidney disease is a thoroughfare of factors threatening safe administration of medicines. Principal among these is reduced kidney function because almost half of all medications used are eliminated
the kidney. Additionally, kidney patients often suffer from multimorbidity, including diabetes, hypertension, and heart failure, with a range of prescribers who often do not coordinate treatments. Patients with kidney disease are also susceptible to further kidney injury and metabolic derangements from medications, which can worsen the disease. In this review, we will present the key issues and threats to safe medication use in kidney disease, with a focus on predialysis CKD, as the scope of medication safety in ESKD and transplantation are unique and deserve their own consideration. We discuss drugs that need to be avoided or dose modified, and review the complications of a range of medications routinely administered in CKD, as these also call for cautious use. |
doi_str_mv | 10.2215/CJN.00580118 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6237057</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2057122621</sourcerecordid><originalsourceid>FETCH-LOGICAL-c427t-79c2c678369fded55ebdc3430d2541dcaa4f9f8b3abf583a3c3b7be705933c213</originalsourceid><addsrcrecordid>eNpVkMtLxDAQh4Mo7rp68yw9erBrnm1zEaS-XR-ggreQ5qGRblqTrrD_vdV9oKeZYT6-GX4A7CM4xhix4_LmfgwhKyBCxQYYIsZYyiF73Vz3FA3ATowfEFJKMNsGA8w5YoigIYB3RjslO9f45Ela082Tx-C8cm1tYiK97kepOqdM4nxS3p7tgi0r62j2lnUEXi7On8urdPJweV2eTlJFcd6lOVdYZXlBMm610YyZSitCCdSYUaSVlNRyW1REVpYVRBJFqrwyOWScEIURGYGThbedVVOjlfFdkLVog5vKMBeNdOL_xrt38dZ8iQyT3pL3gsOlIDSfMxM7MXVRmbqW3jSzKHAPIYyz31tHC1SFJsZg7PoMguInZNGHLFYh9_jB39fW8CpV8g0dGXb8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2057122621</pqid></control><display><type>article</type><title>Medication Safety Principles and Practice in CKD</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Whittaker, Chanel F ; Miklich, Margaret A ; Patel, Roshni S ; Fink, Jeffrey C</creator><creatorcontrib>Whittaker, Chanel F ; Miklich, Margaret A ; Patel, Roshni S ; Fink, Jeffrey C</creatorcontrib><description>Ensuring patient safety is a priority of medical care because iatrogenic injury has been a primary concern. Medications are an important source of medical errors, and kidney disease is a thoroughfare of factors threatening safe administration of medicines. Principal among these is reduced kidney function because almost half of all medications used are eliminated
the kidney. Additionally, kidney patients often suffer from multimorbidity, including diabetes, hypertension, and heart failure, with a range of prescribers who often do not coordinate treatments. Patients with kidney disease are also susceptible to further kidney injury and metabolic derangements from medications, which can worsen the disease. In this review, we will present the key issues and threats to safe medication use in kidney disease, with a focus on predialysis CKD, as the scope of medication safety in ESKD and transplantation are unique and deserve their own consideration. We discuss drugs that need to be avoided or dose modified, and review the complications of a range of medications routinely administered in CKD, as these also call for cautious use.</description><identifier>ISSN: 1555-9041</identifier><identifier>ISSN: 1555-905X</identifier><identifier>EISSN: 1555-905X</identifier><identifier>DOI: 10.2215/CJN.00580118</identifier><identifier>PMID: 29915131</identifier><language>eng</language><publisher>United States: American Society of Nephrology</publisher><subject>Acute Kidney Injury - chemically induced ; Anemia - drug therapy ; Anemia - etiology ; Anemia - therapy ; Angiotensin Receptor Antagonists - adverse effects ; Angiotensin-Converting Enzyme Inhibitors - adverse effects ; Chronic Kidney Disease-Mineral and Bone Disorder - drug therapy ; Chronic Kidney Disease-Mineral and Bone Disorder - etiology ; Diuretics - adverse effects ; Humans ; Hyperkalemia - drug therapy ; Hyperkalemia - etiology ; Hypoglycemic Agents - adverse effects ; Hypokalemia - drug therapy ; Hypokalemia - etiology ; Kidney Failure, Chronic - physiopathology ; Kidney Transplantation ; Medication Reconciliation ; Nephropharmacology for the Clinician ; Patient Safety ; Renal Insufficiency, Chronic - complications ; Renal Insufficiency, Chronic - physiopathology</subject><ispartof>Clinical journal of the American Society of Nephrology, 2018-11, Vol.13 (11), p.1738-1746</ispartof><rights>Copyright © 2018 by the American Society of Nephrology.</rights><rights>Copyright © 2018 by the American Society of Nephrology 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c427t-79c2c678369fded55ebdc3430d2541dcaa4f9f8b3abf583a3c3b7be705933c213</citedby><cites>FETCH-LOGICAL-c427t-79c2c678369fded55ebdc3430d2541dcaa4f9f8b3abf583a3c3b7be705933c213</cites><orcidid>0000-0001-7877-897 ; 0000-0002-1075-7459</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237057/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237057/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29915131$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Whittaker, Chanel F</creatorcontrib><creatorcontrib>Miklich, Margaret A</creatorcontrib><creatorcontrib>Patel, Roshni S</creatorcontrib><creatorcontrib>Fink, Jeffrey C</creatorcontrib><title>Medication Safety Principles and Practice in CKD</title><title>Clinical journal of the American Society of Nephrology</title><addtitle>Clin J Am Soc Nephrol</addtitle><description>Ensuring patient safety is a priority of medical care because iatrogenic injury has been a primary concern. Medications are an important source of medical errors, and kidney disease is a thoroughfare of factors threatening safe administration of medicines. Principal among these is reduced kidney function because almost half of all medications used are eliminated
the kidney. Additionally, kidney patients often suffer from multimorbidity, including diabetes, hypertension, and heart failure, with a range of prescribers who often do not coordinate treatments. Patients with kidney disease are also susceptible to further kidney injury and metabolic derangements from medications, which can worsen the disease. In this review, we will present the key issues and threats to safe medication use in kidney disease, with a focus on predialysis CKD, as the scope of medication safety in ESKD and transplantation are unique and deserve their own consideration. We discuss drugs that need to be avoided or dose modified, and review the complications of a range of medications routinely administered in CKD, as these also call for cautious use.</description><subject>Acute Kidney Injury - chemically induced</subject><subject>Anemia - drug therapy</subject><subject>Anemia - etiology</subject><subject>Anemia - therapy</subject><subject>Angiotensin Receptor Antagonists - adverse effects</subject><subject>Angiotensin-Converting Enzyme Inhibitors - adverse effects</subject><subject>Chronic Kidney Disease-Mineral and Bone Disorder - drug therapy</subject><subject>Chronic Kidney Disease-Mineral and Bone Disorder - etiology</subject><subject>Diuretics - adverse effects</subject><subject>Humans</subject><subject>Hyperkalemia - drug therapy</subject><subject>Hyperkalemia - etiology</subject><subject>Hypoglycemic Agents - adverse effects</subject><subject>Hypokalemia - drug therapy</subject><subject>Hypokalemia - etiology</subject><subject>Kidney Failure, Chronic - physiopathology</subject><subject>Kidney Transplantation</subject><subject>Medication Reconciliation</subject><subject>Nephropharmacology for the Clinician</subject><subject>Patient Safety</subject><subject>Renal Insufficiency, Chronic - complications</subject><subject>Renal Insufficiency, Chronic - physiopathology</subject><issn>1555-9041</issn><issn>1555-905X</issn><issn>1555-905X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkMtLxDAQh4Mo7rp68yw9erBrnm1zEaS-XR-ggreQ5qGRblqTrrD_vdV9oKeZYT6-GX4A7CM4xhix4_LmfgwhKyBCxQYYIsZYyiF73Vz3FA3ATowfEFJKMNsGA8w5YoigIYB3RjslO9f45Ela082Tx-C8cm1tYiK97kepOqdM4nxS3p7tgi0r62j2lnUEXi7On8urdPJweV2eTlJFcd6lOVdYZXlBMm610YyZSitCCdSYUaSVlNRyW1REVpYVRBJFqrwyOWScEIURGYGThbedVVOjlfFdkLVog5vKMBeNdOL_xrt38dZ8iQyT3pL3gsOlIDSfMxM7MXVRmbqW3jSzKHAPIYyz31tHC1SFJsZg7PoMguInZNGHLFYh9_jB39fW8CpV8g0dGXb8</recordid><startdate>20181107</startdate><enddate>20181107</enddate><creator>Whittaker, Chanel F</creator><creator>Miklich, Margaret A</creator><creator>Patel, Roshni S</creator><creator>Fink, Jeffrey C</creator><general>American Society of Nephrology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-7877-897</orcidid><orcidid>https://orcid.org/0000-0002-1075-7459</orcidid></search><sort><creationdate>20181107</creationdate><title>Medication Safety Principles and Practice in CKD</title><author>Whittaker, Chanel F ; Miklich, Margaret A ; Patel, Roshni S ; Fink, Jeffrey C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c427t-79c2c678369fded55ebdc3430d2541dcaa4f9f8b3abf583a3c3b7be705933c213</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Acute Kidney Injury - chemically induced</topic><topic>Anemia - drug therapy</topic><topic>Anemia - etiology</topic><topic>Anemia - therapy</topic><topic>Angiotensin Receptor Antagonists - adverse effects</topic><topic>Angiotensin-Converting Enzyme Inhibitors - adverse effects</topic><topic>Chronic Kidney Disease-Mineral and Bone Disorder - drug therapy</topic><topic>Chronic Kidney Disease-Mineral and Bone Disorder - etiology</topic><topic>Diuretics - adverse effects</topic><topic>Humans</topic><topic>Hyperkalemia - drug therapy</topic><topic>Hyperkalemia - etiology</topic><topic>Hypoglycemic Agents - adverse effects</topic><topic>Hypokalemia - drug therapy</topic><topic>Hypokalemia - etiology</topic><topic>Kidney Failure, Chronic - physiopathology</topic><topic>Kidney Transplantation</topic><topic>Medication Reconciliation</topic><topic>Nephropharmacology for the Clinician</topic><topic>Patient Safety</topic><topic>Renal Insufficiency, Chronic - complications</topic><topic>Renal Insufficiency, Chronic - physiopathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Whittaker, Chanel F</creatorcontrib><creatorcontrib>Miklich, Margaret A</creatorcontrib><creatorcontrib>Patel, Roshni S</creatorcontrib><creatorcontrib>Fink, Jeffrey C</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical journal of the American Society of Nephrology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Whittaker, Chanel F</au><au>Miklich, Margaret A</au><au>Patel, Roshni S</au><au>Fink, Jeffrey C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Medication Safety Principles and Practice in CKD</atitle><jtitle>Clinical journal of the American Society of Nephrology</jtitle><addtitle>Clin J Am Soc Nephrol</addtitle><date>2018-11-07</date><risdate>2018</risdate><volume>13</volume><issue>11</issue><spage>1738</spage><epage>1746</epage><pages>1738-1746</pages><issn>1555-9041</issn><issn>1555-905X</issn><eissn>1555-905X</eissn><abstract>Ensuring patient safety is a priority of medical care because iatrogenic injury has been a primary concern. Medications are an important source of medical errors, and kidney disease is a thoroughfare of factors threatening safe administration of medicines. Principal among these is reduced kidney function because almost half of all medications used are eliminated
the kidney. Additionally, kidney patients often suffer from multimorbidity, including diabetes, hypertension, and heart failure, with a range of prescribers who often do not coordinate treatments. Patients with kidney disease are also susceptible to further kidney injury and metabolic derangements from medications, which can worsen the disease. In this review, we will present the key issues and threats to safe medication use in kidney disease, with a focus on predialysis CKD, as the scope of medication safety in ESKD and transplantation are unique and deserve their own consideration. We discuss drugs that need to be avoided or dose modified, and review the complications of a range of medications routinely administered in CKD, as these also call for cautious use.</abstract><cop>United States</cop><pub>American Society of Nephrology</pub><pmid>29915131</pmid><doi>10.2215/CJN.00580118</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0001-7877-897</orcidid><orcidid>https://orcid.org/0000-0002-1075-7459</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1555-9041 |
ispartof | Clinical journal of the American Society of Nephrology, 2018-11, Vol.13 (11), p.1738-1746 |
issn | 1555-9041 1555-905X 1555-905X |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6237057 |
source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection |
subjects | Acute Kidney Injury - chemically induced Anemia - drug therapy Anemia - etiology Anemia - therapy Angiotensin Receptor Antagonists - adverse effects Angiotensin-Converting Enzyme Inhibitors - adverse effects Chronic Kidney Disease-Mineral and Bone Disorder - drug therapy Chronic Kidney Disease-Mineral and Bone Disorder - etiology Diuretics - adverse effects Humans Hyperkalemia - drug therapy Hyperkalemia - etiology Hypoglycemic Agents - adverse effects Hypokalemia - drug therapy Hypokalemia - etiology Kidney Failure, Chronic - physiopathology Kidney Transplantation Medication Reconciliation Nephropharmacology for the Clinician Patient Safety Renal Insufficiency, Chronic - complications Renal Insufficiency, Chronic - physiopathology |
title | Medication Safety Principles and Practice in CKD |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T21%3A49%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Medication%20Safety%20Principles%20and%20Practice%20in%20CKD&rft.jtitle=Clinical%20journal%20of%20the%20American%20Society%20of%20Nephrology&rft.au=Whittaker,%20Chanel%20F&rft.date=2018-11-07&rft.volume=13&rft.issue=11&rft.spage=1738&rft.epage=1746&rft.pages=1738-1746&rft.issn=1555-9041&rft.eissn=1555-905X&rft_id=info:doi/10.2215/CJN.00580118&rft_dat=%3Cproquest_pubme%3E2057122621%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2057122621&rft_id=info:pmid/29915131&rfr_iscdi=true |